The Sackler family will now relinquish control of Purdue Pharma and cease sale of opioids in the U.S. as part of a $7.4 billion settlement.

Purdue Pharma and Sackler family members who own the company have reached a $7.4 billion settlement with all 50 states and U.S. territories over the company's improper marketing of opioids.

Fifty-five attorneys general around the country have now signed on to a $7.4 billion settlement with drugmaker Purdue Pharma and its owners, the Sackler family, over the opioid crisis, officials said.

A narrowly divided Supreme Court in a 5-4 decision struck down a hard-fought bankruptcy plan for OxyContin manufacturer Purdue Pharma that would have awarded $6 billion to state and local ...

Arkansas will receive $44.5 million annually for 17 years as part of a settlement with Purdue Pharma and the Sackler family, with one-third of the funds allocated to the state and the remaining ...

Purdue Pharma’s $7B opioid settlement plan could get votes from victims and cities Members of the Sackler family who own the company would pay up to $7 billion and give up ownership on the company.

A member of the Sackler family, which owns OxyContin-maker Purdue Pharma, expressed "sadness" over the nation's opioid epidemic during a congressional hearing Thursday that marked the first time ...

Purdue Pharma’s $7B opioid settlement could advance after states back it The deal calls for members of the Sackler family who own the company to give up ownership and to contribute up to $7 ...

A $7.4 billion settlement with Purdue Pharma and its owners, the Sackler family, was agreed to be signed by 55 attorneys general representing states and United States territories, Attorney General ...